You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Saxagliptin

Showing 1 - 25 of 160
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in India (dapagliflozin and saxagliptin)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • dapagliflozin and saxagliptin
  • Bangalore, India
  • +8 more
Jan 17, 2023

Type 2 Diabetes Trial in Bangkok, Ho Chi Minh (Dapagliflozin 10 mg, Dapagliflozin 5 mg, Dapagliflozin 10 mg to match)

Terminated
  • Type 2 Diabetes Mellitus
  • Dapagliflozin 10 mg
  • +5 more
  • Bangkok, Thailand
  • +3 more
May 25, 2022

Diabetes, Type 2, Cardiovascular Diseases Trial in Washington (Dapagliflozin 10mg, Saxagliptin 5mg, Placebo Oral Tablet)

Terminated
  • Diabetes Mellitus, Type 2
  • Cardiovascular Diseases
  • Dapagliflozin 10mg
  • +2 more
  • Washington, District of Columbia
    The GW Medical Faculty Associates
Mar 21, 2022

Harmonizing RCT-Duplicate Emulations In A Real World Replication

Completed
  • Type 2 Diabetes Mellitus
  • Gothenburg, Sweden
    Research Site
Oct 23, 2023

Cognitive Protective Effect of Newer Antidiabetic Drugs

Recruiting
  • Type 2 Diabetes
  • Alexandria, Egypt
    Alexandria University
Jul 24, 2022

Four Second Line Pharmacological Strategies in Type 2 Diabetes

Active, not recruiting
  • Cardiovascular Events
  • +2 more
  • SGLT2 inhibitor
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 17, 2022

Type2diabetes Trial in Nasiriyah, Basrah (Insulin Glargine 100 UNT/ML Pen Injector [Lantus], Saxagliptin 2.5 mg/ Metformin

Not yet recruiting
  • Type2diabetes
  • Insulin Glargine 100 UNT/ML Pen Injector [Lantus]
  • +2 more
  • Nasiriyah, Thi Qar, Iraq
  • +1 more
Oct 28, 2023

Diabetes, Type 2, Impaired Glucose Tolerance (IGT), Impaired Fasting Glucose (IFG) Trial in San Antonio (Dapagliflozin,

Recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • San Antonio, Texas
    The University of Texas Health Science Center at San Antonio
Aug 29, 2022

Comparison of Type 2 Diabetes Pharmacotherapy Regimens

Recruiting
  • Type 2 Diabetes Mellitus
  • Cardiovascular Diseases
  • Oakland, California
  • +5 more
Oct 18, 2022

Diabetes, Type 2 Trial in Al Qahirah Al Jadidah (Saxagliptin 5mg)

Completed
  • Diabetes Mellitus, Type 2
  • Saxagliptin 5mg
  • Al Qāhirah Al Jadīdah, Egypt
    Faculty of Pharmacy
Aug 18, 2020

Type 2 Diabetes, Heart Failure Trial in Worldwide (Saxagliptin, Sitagliptin, Placebo to match saxagliptin)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Heart Failure
  • Saxagliptin
  • +3 more
  • Torrance, California
  • +73 more
Nov 5, 2021

SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of

Unknown status
  • Type 2 Diabetes
  • Urinary Tract Infections
  • Empagliflozin / Linagliptin or Dapagliflozin/Saxagliptin Pill
  • Empagliflozin or Dapagliflozin Pill
  • Pisa, Italy
    University of Pisa
Jan 27, 2021

Type 2 Diabetes, Insulin Resistance Trial in Pittsburgh (Metformin, saxagliptin, AZD9668)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Insulin Resistance
  • Pittsburgh, Pennsylvania
    Allegheny Health Network
Apr 22, 2021

Diabetes, Non-Insulin-Dependent, Heart Failure Trial in Toronto (Saxagliptin, saxagliptin)

Completed
  • Diabetes Mellitus, Non-Insulin-Dependent
  • Heart Failure
  • Saxagliptin
  • saxagliptin
  • Toronto, Ontario, Canada
    St Michael's Hospital
Mar 26, 2020

Diabetes, Type 2 Trial in Worldwide (Dapagliflozin, Saxagliptin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Sacramento, California
  • +122 more
Mar 21, 2022

Type 2 Diabetes (T2DM) Trial in Phoenix (Saxagliptin, Placebo)

Completed
  • Type 2 Diabetes Mellitus (T2DM)
  • Saxagliptin
  • Placebo
  • Phoenix, Arizona
    Carl T. Hayden VA Medical Hospital
Mar 11, 2020

Diabetes, Type 1 Trial in China (Saxagliptin, Vitamin D3, Insulin)

Completed
  • Diabetes Mellitus, Type 1
  • Saxagliptin
  • +3 more
  • Peking, Beijing, China
  • +38 more
Apr 18, 2021

Type 2 Diabetes Trial in Tübingen (Dapagliflozin 10 mg + Saxagliptin 5 mg, Placebo 1 10 mg + Placebo 2 5 mg)

Terminated
  • Type 2 Diabetes
  • Dapagliflozin 10 mg + Saxagliptin 5 mg
  • Placebo 1 10 mg + Placebo 2 5 mg
  • Tübingen, Germany
    University Hospital Tübingen
Feb 7, 2020

Impaired Glucose Tolerance Trial in Houston (Saxagliptin, Placebo)

Terminated
Has Results
  • Impaired Glucose Tolerance
  • Saxagliptin
  • Placebo
  • Houston, Texas
    Baylor College of Medicine
Dec 24, 2019

Diabetes, Type 2, Erectile Dysfunction With Diabetes, Drug Interaction Trial (Saxagliptin 5mg, Sildenafil 50 mg)

Unknown status
  • Diabetes Mellitus, Type 2
  • +2 more
  • Saxagliptin 5mg
  • Sildenafil 50 mg
  • (no location specified)
Nov 19, 2019

Platelet Aggregation During Acute Myocardial Infarction Trial in São Paulo (sitagliptin OR saxagliptin, )

Completed
  • Platelet Aggregation During Acute Myocardial Infarction
  • sitagliptin OR saxagliptin
  • placebo
  • São Paulo, SP, Brazil
    Heart Institute(InCor)-Acute Coronary Care Unit
Aug 26, 2020

ive Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

Active, not recruiting
  • Diabetes
  • Boston, Massachusetts
    Brigham and Women's Hospital
Mar 3, 2023

Replication of SAVOR-TIMI Diabetes Trial in Healthcare Claims

Unknown status
  • Diabetes
  • Boston, Massachusetts
    Brigham & Women's Hospital
Dec 30, 2019

Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Glimepiride)

Completed
Has Results
  • Diabetes
  • Saxagliptin
  • +3 more
  • Birmingham, Alabama
  • +83 more
Jun 22, 2020

Diabetes, Type 2 Trial in San Antonio (Saxagliptin, Dapagliflozin, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Saxagliptin
  • +2 more
  • San Antonio, Texas
    The University of Texas Health Science Center at San Antonio
Jul 22, 2019